Synthetic Biologics competitorsClear all

Synthetic Biologics's top competitors include Vertex Pharmaceuticals, MyoKardia and Athersys.
Synthetic Biologics
Synthetic Biologics
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Founding Date
Founding Date
2001
Founding Date
1989
Founding Date
2012
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Toronto, CA
see more
Locations
South San Francisco, US HQ
Brisbane, US
Locations
Cleveland, US HQ
Canton, US
Employees
Employees
1115% decrease
Employees
3,00020% increase
Employees
23542% increase
Employees
8311% increase
Valuation ($)
Valuation ($)
6.5 m
Valuation ($)
57.4 b
Valuation ($)
11.8 b
Valuation ($)
353.4 m
Twitter followers
Twitter followers
1.3 k
Twitter followers
64.7 k
Twitter followers
1.1 k
Twitter followers
2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
17.7
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
34.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
352754
Alexa Website Rank
145684
Alexa Website Rank
239431
Alexa Website Rank
322595
Employee Rating
Employee Rating
N/A
Employee Rating
3.3
Employee Rating
4.2
Employee Rating
5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$4.2b (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$5.6m (FY, 2019)
Net income
Net income
($15.3m) (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
($276.2m) (FY, 2019)
Net income
($44.6m) (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
2 (FY, 2018)
Patents (US)
21 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 16.1m
Total funding raised
$ 2.4m
Total funding raised
$ 98m
Total funding raised
$ 9m
For sources of this data, please see the company profile

View company profiles

Vertex Pharmaceuticals
HQ
Boston, US
Employees
3,000↑ 20% increase

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company